Research and Clinical Trials
At Midwest Chest Consultants in St. Charles, Missouri, we are dedicated to providing the highest standard of care for patients with pulmonary disorders and diseases. For this reason, we’ve made a point of getting and staying involved in research studies that can improve the standard of care.
In addition to our pulmonology practice, we run a full-time clinical trials operation. We have dedicated full-time professionals devoted to this part of our practice and to ensuring the most complete, thorough, and accurate information and patient care.
Since 1991, we have conducted nearly 175 different clinical trials, and we’re in demand by pharmaceutical companies who require top-quality investigative data. We are presently conducting several studies on COPD and asthma, and we have more planned for the future.
A clinical research study is also called a clinical trial. Each study tests the safety, effectiveness, and side effects of an investigational medicine(s) or an investigational device on a group of volunteers. Clinical research studies are an important step in making new investigational medications available for future use.
Every day, research uncovers new information about diseases and their treatment. By taking part in a clinical research study, you are an important link in a long chain of research and testing of new investigational medicines for future use.
With decades of experience as pulmonologists and investigators, we know that patients — particularly those with COPD — are interested in receiving closer care. In other words, they desire more hands-on time with the specialist, which is a key motivator for patients to participate in clinical trials. This is particularly the case for patients who are still struggling with their illness despite treatment.
Patients considering participation in COPD studies also benefit simply from the screening process. Regardless of whether they are chosen for the study, they receive a “snapshot” of their lung function (spirometry) at no cost.
Other motivators include:
- Greater frequency of specialty tests and exams
- Zero-cost medications and care
- Priority visits
- Reimbursement for time and expenses
- Potential for effective relief that has otherwise been elusive
Today, most pharmaceutical companies that are researching new treatments desire a particular type of COPD patient. For starters, because age is an important factor in the incidence of COPD, patients must be age 40 or older in order to be eligible. A personal history of smoking is also a key eligibility factor, and the ideal candidate is a COPD patient who has a history of one or more packs per day for 10 or more years.
If you are 18 years of age or older you may be eligible for a study. Typically, patients with an extensive smoking history are not eligible.
Do You Have COPD or Asthma? Ask about Our Clinical Trials in St. Charles, MO
If you or someone you know is interested in a clinical trial, please call Midwest Chest Consultants in St. Charles, Missouri today at (636) 946-1650 for more information.